Fauci: Gilead’s Remdesivir Drug Trials Show ‘Good News’ Against Covid-19 Fight

Gilead Sciences Inc. said early results from a U.S.-government-run study showed its experimental drug to treat coronavirus helped patients recover more quickly than standard care, suggesting it could become the first effective treatment for an illness that has turned modern life inside-out.

The company issued a news release early Wednesday commenting on the study from the U.S. National Institute of Allergy and Infectious Diseases without providing details of the results.

Anthony Fauci, the head of NIAID and the government’s top infectious-disease specialist, said at a White House meeting with President Donald Trump and Louisiana Governor John Bel Edwards that the trial showed a significant positive effect on the virus and that the results “were quite good news.”

Fauci called the study the “first truly high-powered randomized placebo-controlled trial” of remdesivir.

Gilead’s share price and the broader stock market have been churned in recent weeks by a series of early looks and leaks of trial data on the drug, called remdesivir. Last week, the market swooned after apparently discouraging results from a Chinese trial were accidentally posted on a World Health Organization web page. Data confirming those more downbeat results were published in the U.K. medical journal The Lancet on Wednesday.

Gilead shares jumped as much as 7.1% Wednesday after the company’s statement. The news appeared to boost the entire U.S. stock market as well, with the S&P 500 gaining 2.4% despite data showing a deep contraction in the U.S. economy in the first quarter of the year.

Remdesivir, which was originally developed to treat other novel viruses, has placed Gilead at the head of the race to develop a treatment for Covid-19. The drug, which has also been tested on Ebola, hasn’t been approved for use anywhere in the world.

A separate study released by Gilead on Wednesday said remdesivir appears equally effective when it’s given over just five days, rather than the 10-day course used in the NIAID and other trials. But the Gilead study doesn’t have a comparison group, so its findings are considered less robust.

The five-day regimen “could significantly expand the number of patients who could be treated with our current supply of remdesivir,” said Merdad Parsey, Gilead’s chief medical officer.

Taken together, the studies could signal a profound shift in the race to get the novel coronavirus under control. The availability of a treatment could allow the world to start reopening economies, as well as offer psychological relief to billions of people who have been self-isolating to hide from the virus.

In the most severe cases, Covid-19 can lead to respiratory failure and death. More than 1 million cases have been confirmed in the U.S., and over 200,000 people have died around the globe from the illness.

Multiple trials of the drug are being conducted. The NIAID trial measured how quickly patients taking it were able to be removed from supplemental oxygen therapy or were discharged from the hospital. It’s not known yet how much benefit the Gilead drug gave patients, and if it will make a meaningful difference in their care.

The trial, run by the National Institutes of Health, aimed to sign up about 800 patients to test the drug and give a definitive answer as to whether it can help treat the illness.

An NIAID representative said in an email that the agency is planning an announcement Wednesday, with the most likely venue the White House task-force briefing.

Gilead’s study of 397 patients with severe disease found those given the drug for five days did just as well as those who were treated for twice as long, and in some cases appeared to fare even better.

Two weeks after treatment, 65% of those who got the five day dose had recovered, compared with just 54% of those who received the infusion for 10 days. The death rate showed a similar trend, with 8% of patients getting less drug dying, compared with 11% in the 10 day group. The difference wasn’t statistically significant, which means it could have happened by chance.

Remdesivir will likely be approved for use in certain settings on the basis of the positive result, said Jefferies health-care strategist Jared Holz, at least until better alternatives are available.

“There is a massive bias to look at the data with half-glass-full approach,” he said, adding that it’s “totally fair given the current predicament.”

Subscribe to our YouTube channel: https://bit.ly/2TwO8Gm

QUICKTAKE ON SOCIAL:
Follow QuickTake on Twitter: twitter.com/quicktake
Like QuickTake on Facebook: facebook.com/quicktake
Follow QuickTake on Instagram: instagram.com/quicktake
Subscribe to our newsletter: https://bit.ly/2FJ0oQZ
Email us at quicktakenews@gmail.com

QuickTake by Bloomberg is a global news network delivering up-to-the-minute analysis on the biggest news, trends and ideas for a new generation of leaders.

About This Source - Bloomberg QuickTake

QuickTake by Bloomberg is a global news network delivering up-to-the-minute analysis on the biggest news, trends and ideas for a new generation of leaders.

Bloomberg L.P. is a privately held financial, software, data, and media company headquartered in Midtown Manhattan, New York City. It was founded by Michael Bloomberg in 1981, with the help of Thomas Secunda, Duncan MacMillan, Charles Zegar, and a 12% ownership investment by Merrill Lynch.

Recent from Bloomberg QuickTake:

  • New York Governor Cuomo: Trump Administration Fueling “Politics of Division”
  • U.S. Protests: Mayor de Blasio Responds to Police Vehicle Driving Into Crowd in New York
  • NASA Administrator Explains Weather Mishap Ahead of Second Try for Historic SpaceX Launch
  • In This Story: Allergy

    Allergies are a number of conditions caused by hypersensitivity of the immune system to typically harmless substances in the environment. These include hay fever, food allergies, atopic dermatitis, allergic asthma, and anaphylaxis. Symptoms may include red eyes, an itchy rash, sneezing, a runny nose, shortness of breath, or swelling.

    Common allergens include pollen and certain foods. Metals and other substances may also cause problems. Food, insect stings, and medications are common causes of severe reactions. Their development is due to both genetic and environmental factors.

    Treatments for allergies include the avoidance of known allergens and the use of medications such as steroids and antihistamines. In severe reactions injectable adrenaline (epinephrine) is recommended.

    Allergies are common. In the developed world, about 20% of people are affected by allergic rhinitis, about 6% of people have at least one food allergy, and about 20% have atopic dermatitis at some point in time. Depending on the country about 1–18% of people have asthma. Anaphylaxis occurs in between 0.05–2% of people.

    Source: Wikipedia

    2 Recent Items: Allergy

  • Fauci: Data For Moderna, Johnson & Johnson Booster Shots Is ‘A Few weeks’ Out
  • White House offered Nicki Minaj call on coronavirus vaccine
  • In This Story: COVID-19

    Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

    Symptoms of coronavirus

    The main symptoms of coronavirus are:

    • a persistent new cough (non productive, dry)
    • a high temperature (e.g. head feels warm to the touch)
    • shortness of breath (if this is abnormal for the individual, or increased)

    Latest News about Covid-19

    Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

    5 Recent Items: COVID-19

  • Tom Fletcher and Strictly Come Dancing partner test positive for Covid | ITV News
  • President Biden Gets Covid-19 Booster Shot
  • No Time To Die: ‘Patience has paid off’, say Bond stars
  • Organ Damage Seen in Many Long Covid Patients, Study Finds
  • See Biden get his Covid-19 booster shot while talking to the press
  • In This Story: Donald Trump

    Donald John Trump was the 45th President of the United States. Before entering politics, he was a businessman and television personality. Trump was born and raised in Queens, a borough of New York City, and received a bachelor’s degree in economics from the Wharton School.

    5 Recent Items: Donald Trump

  • Trump confesses to pressuring Georgia governor to overturn 2020 election results
  • Republican lawmaker suggests second 2020 presidential election
  • Trump honors Marine who rescued Afghan baby in viral video
  • YouTube CEO Wojcicki on Reinstating Trump: We’ll Evaluate
  • Meet The Press Broadcast (Full) – September 26th, 2021
  • In This Story: Louisiana

    Louisiana is a southeastern U.S. state on the Gulf of Mexico. Its history as a melting pot of French, African, American and French-Canadian cultures is reflected in its Creole and Cajun cultures. The largest city, New Orleans, is known for its colonial-era French Quarter, raucous Mardi Gras festival, jazz music, Renaissance-style St. Louis Cathedral and wartime exhibits at the huge National WWII Museum.

    4 Recent Items: Louisiana

  • Hurricane Ida Power Grid Failure Forces Reckoning Over Entergy’s Monopoly
  • Louisiana Seafood Businesses Struggle to Recover After Hurricane Ida
  • Sen. Kennedy: Biden administration ‘lies like they breathe’
  • Families affected by catastrophic Hurricane Ida are rescued
  • Leave a Comment

    We don't require your email address now, just your name. BUT, if you do add it, you may be notified if there are replies to your comment. Please make respectful comments, which add value, and avoid personal attacks on others. Comments failing to adhere to these guidelines will not be published.